Targeting USPs as breast cancer treatment is especially promising due to the recent expansion of the role of several USPs in the regulation of various cancer-related pathways such as TGFβ signaling at multiple levels within the pathway. This evidence concerns the gene TGFB1 and breast carcinoma.